Jones PW - Search Results

1

Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.

Tomaszewski EL, Atkinson MJ, Janson C, Karlsson N, Make B, Price D, Reddel HK, Vogelmeier CF, Müllerová H, Jones PW; NOVELTY Scientific Community; NOVELTY study investigators. Tomaszewski EL, et al. Among authors: jones pw. Respir Res. 2023 Apr 8;24(1):106. doi: 10.1186/s12931-023-02394-6. Respir Res. 2023. PMID: 37031164 Free PMC article.

2

Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia?

Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Okubadejo AA, et al. Among authors: jones pw. Eur Respir J. 1996 Nov;9(11):2335-9. doi: 10.1183/09031936.96.09112335. Eur Respir J. 1996. PMID: 8947081 Free article.

3

Home assessment of activities of daily living in patients with severe chronic obstructive pulmonary disease on long-term oxygen therapy.

Okubadejo AA, O'Shea L, Jones PW, Wedzicha JA. Okubadejo AA, et al. Among authors: jones pw. Eur Respir J. 1997 Jul;10(7):1572-5. doi: 10.1183/09031936.97.10071572. Eur Respir J. 1997. PMID: 9230249 Free article.

4

Validation of the St. George's Respiratory Questionnaire in bronchiectasis.

Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Wilson CB, et al. Among authors: jones pw. Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 1):536-41. doi: 10.1164/ajrccm.156.2.9607083. Am J Respir Crit Care Med. 1997. PMID: 9279236

5

Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction.

Foglio K, Carone M, Pagani M, Bianchi L, Jones PW, Ambrosino N. Foglio K, et al. Among authors: jones pw. Respir Med. 2000 Mar;94(3):256-63. doi: 10.1053/rmed.1999.0734. Respir Med. 2000. PMID: 10783937 Free article.

6

Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL).

Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW. Garrod R, et al. Among authors: jones pw. Respir Med. 2000 Jun;94(6):589-96. doi: 10.1053/rmed.2000.0786. Respir Med. 2000. PMID: 10921765 Free article.

7

Interpreting thresholds for a clinically significant change in health status in asthma and COPD.

Jones PW. Jones PW. Eur Respir J. 2002 Mar;19(3):398-404. doi: 10.1183/09031936.02.00063702. Eur Respir J. 2002. PMID: 11936514 Free article. Review.

8

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Calverley P, et al. Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2. Lancet. 2003. PMID: 12583942 Clinical Trial.

9

Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD.

Vestbo J, Soriano JB, Anderson JA, Calverley P, Pauwels R, Jones P; TRISTAN Study Group. Vestbo J, et al. Respir Med. 2004 Nov;98(11):1045-50. doi: 10.1016/j.rmed.2004.03.017. Respir Med. 2004. PMID: 15526804 Free article. Clinical Trial.

10

Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.

Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P; TRISTSAN study group. Vestbo J, et al. Thorax. 2005 Apr;60(4):301-4. doi: 10.1136/thx.2004.025411. Thorax. 2005. PMID: 15790985 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

667 results

Search Page

Filters